Most Read Articles
5 days ago
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
Roshini Claire Anthony, 11 Oct 2017

The prevalence of resistant hypertension may be lower than expected, particularly once pseudo-resistant hypertension due to treatment nonadherence is taken into account, according to a presentation at the recent APCH 2017.

Pank Jit Sin, 07 Jan 2015

Cardiovascular diseases (CVD) have been the main cause of death in the Malaysian population since 2007. This trend has continued, with the number of people dying from CVD-related causes increasing year on year. 

Tristan Manalac, 6 days ago
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.

Peripheral, not central, BP correlates better with hypertensive target organ damage

18 Sep 2017

The presence of target organ damage (TOD) in hypertension is more likely to result in blood pressure (BP) elevation, independently of the type of measurement (office or ambulatory, central or peripheral), according to a recent study. Central BP, even monitored during 24 hours, is not better correlated with TOD than peripheral BP.

Researchers performed a cross-sectional study of 208 hypertensive patients (mean age 57±12 years; 34 percent women) to examine the association of 24-hour central BP, in comparison with 24-hour peripheral BP, with the presence of TOD.

The oscillometric Mobil-O-Graph device was used to measure office (mean of four measurements) and 24-hour central and peripheral BP. The investigators assessed TOD at cardiac (left ventricular hypertrophy by echocardiography), renal (reduction of glomerular filtration rate and/or microalbuminuria) and arterial (increased aortic pulse wave velocity) levels.

Of the patients, 107 (51.4 percent) had TOD (77 [35 percent] left ventricular hypertrophy; 54 [25.9 percent] renal abnormalities; 40 [19.2 percent] arterial stiffness).

After adjustment for age, sex and antihypertensive treatment, all systolic (S)BP and pulse BP estimates (office, 24-hour, daytime and night-time) correlated with the presence of TOD, with higher odds ratios (ORs) for ambulatory-derived values.

There were similar ORs for central and peripheral BP for all office, 24-hour, daytime and night-time BP. After simultaneous adjustment, peripheral, but not central, 24-hour and night-time SBP and pulse pressures correlated with the presence of TOD.

These findings do not lend support to a routine measurement of 24-hour central BP, which is increasingly considered as a better estimator of hypertension-associated risks, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
5 days ago
Higher circulating levels of docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) appear to be protective against incident atherothrombotic and cardioembolic strokes, respectively, according to a recent study.
Roshini Claire Anthony, 11 Oct 2017

The prevalence of resistant hypertension may be lower than expected, particularly once pseudo-resistant hypertension due to treatment nonadherence is taken into account, according to a presentation at the recent APCH 2017.

Pank Jit Sin, 07 Jan 2015

Cardiovascular diseases (CVD) have been the main cause of death in the Malaysian population since 2007. This trend has continued, with the number of people dying from CVD-related causes increasing year on year. 

Tristan Manalac, 6 days ago
Administration of a long-acting medication at the time that is most suitable for maximum patient compliance is the best approach in controlling blood pressure, said Dr. Trefor Morgan at the recently concluded 13th Asian-Pacific Congress of Hypertension (APCH 2017), held at the Suntec Singapore Convention and Exhibition Centre.